JP2005526061A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526061A5
JP2005526061A5 JP2003574169A JP2003574169A JP2005526061A5 JP 2005526061 A5 JP2005526061 A5 JP 2005526061A5 JP 2003574169 A JP2003574169 A JP 2003574169A JP 2003574169 A JP2003574169 A JP 2003574169A JP 2005526061 A5 JP2005526061 A5 JP 2005526061A5
Authority
JP
Japan
Prior art keywords
release
active ingredient
area
treatment system
incisions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003574169A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526061A (ja
Filing date
Publication date
Priority claimed from IT2002MI000515A external-priority patent/ITMI20020515A1/it
Application filed filed Critical
Publication of JP2005526061A publication Critical patent/JP2005526061A/ja
Publication of JP2005526061A5 publication Critical patent/JP2005526061A5/ja
Pending legal-status Critical Current

Links

JP2003574169A 2002-03-12 2003-03-12 活性成分の放出を制御するためのシステム Pending JP2005526061A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000515A ITMI20020515A1 (it) 2002-03-12 2002-03-12 Sistema per il rilasco controllato di uno o piu' principi attivi
PCT/EP2003/002537 WO2003075894A1 (en) 2002-03-12 2003-03-12 A system for the controlled release of active ingredients

Publications (2)

Publication Number Publication Date
JP2005526061A JP2005526061A (ja) 2005-09-02
JP2005526061A5 true JP2005526061A5 (enExample) 2006-04-20

Family

ID=11449491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003574169A Pending JP2005526061A (ja) 2002-03-12 2003-03-12 活性成分の放出を制御するためのシステム

Country Status (8)

Country Link
US (1) US20050163845A1 (enExample)
EP (1) EP1482913A1 (enExample)
JP (1) JP2005526061A (enExample)
CN (1) CN1649570A (enExample)
AU (1) AU2003214121A1 (enExample)
CA (1) CA2478514A1 (enExample)
IT (1) ITMI20020515A1 (enExample)
WO (1) WO2003075894A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1295926A1 (en) 2001-09-19 2003-03-26 ExxonMobil Chemical Patents Inc. Components for adhesive compositions and process for manufacture
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
AP2006003602A0 (en) * 2003-09-19 2006-04-30 Sun Pharmaceutical Ind Ltd Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
KR100866720B1 (ko) 2004-12-27 2008-11-05 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매 약물의 안정화 방법
CA2715584A1 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd. Oral controlled release tablet
WO2009146537A1 (en) * 2008-06-02 2009-12-10 Pharmascience Inc. Multilayer control-release drug delivery system
EP2163240A1 (en) 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova A method for the production of bioadhesive compact matrices
FR2966731B1 (fr) * 2010-11-03 2013-04-26 Sanofi Aventis Forme pharmaceutique solide marquee et son procede de fabrication par marquage laser

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US5658474A (en) * 1994-12-16 1997-08-19 Alza Corporation Method and apparatus for forming dispenser delivery ports
ES2203963T3 (es) * 1997-05-30 2004-04-16 Osmotica Corp. Dispositivo osmotico multicapa.
DE59804823D1 (de) * 1997-09-25 2002-08-22 Bayer Ag Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
UA67802C2 (uk) * 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
SE9804314D0 (sv) * 1998-12-14 1998-12-14 Astra Ab New pharmaceutical formulation
CA2378829A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano

Similar Documents

Publication Publication Date Title
MY169471A (en) Controlled release preparation
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
AP2001002237A0 (en) Hydrogel-driven drug dosage form.
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
CA2414665A1 (en) Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
HRP20010463B1 (hr) Smjesa s kontroliranim otpuštanjem koja sadrži galantamin
JP2005526061A5 (enExample)
ATE303793T1 (de) Pharmazeutische komposition für verlängerte/langanhaltende freisetzung eines therapeutisch aktiven wirkstoffes
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
DE60321386D1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
WO2006023286A3 (en) Controlled release nanoparticle active agent formulation dosage forms and methods
AU2357202A (en) Ion-strength independent sustained release pharmaceutical formulation
JP2007501248A5 (enExample)
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
CA2417887A1 (en) Particulate composition of eletriptan
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
NO323466B1 (no) Nye kinolinyl-piperidin-4-yliden-metyl-benzamidderivater, fremgangsmate til fremstilling derav, anvendelse derav i medikamenter til behandling av smerte, samt farmasoytisk sammensetning som innbefatter slike derivater
WO2003075894A8 (en) A system for the controlled release of active ingredients
NO20055601D0 (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
JP2002537246A5 (enExample)
JP2005505605A5 (enExample)